6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression-Reference-Cited by-同舟云学术

6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression

Published:2017-03-23 Issue:7 Volume:60 Page:2764-2779
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Liu Yuxiu¹,Qing Lihua²,Meng Chuisong¹,Shi Jiajie²,Yang Yan²,Wang Ziwen¹,Han Guifang¹,Wang Yi²,Ding Jian²,Meng Ling-hua²,Wang Qingmin¹^ORCID

Affiliation:

1. State Key Laboratory of Elemento-Organic Chemistry, Research Institute of Elemento-Organic Chemistry, Nankai University, Tianjin 300071, P. R. China

2. Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, P. R. China

Funder

Natural Science Foundation of Tianjin City

Ministry of Education of the People's Republic of China

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b01502

Reference29 articles.

1. The Antileukemia Activity of Tylocrebrine